E
Cogent Biosciences, Inc. COGT
$12.23 $0.443.73% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -284.08M -269.50M -255.86M -242.30M -227.05M
Total Depreciation and Amortization 4.50M 4.42M 4.35M 4.04M 3.80M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 30.58M 33.18M 32.12M 29.31M 34.81M
Change in Net Operating Assets 15.38M 10.12M 11.60M 17.67M 11.17M
Cash from Operations -233.61M -221.77M -207.79M -191.28M -177.27M
Capital Expenditure -1.03M -1.05M -573.00K -813.00K -654.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 201.18M 107.66M 38.85M -12.09M -162.97M
Cash from Investing 200.15M 106.61M 38.28M -12.91M -163.63M
Total Debt Issued 49.29M -- -- -- --
Total Debt Repaid -2.07M -- -- -- --
Issuance of Common Stock 26.43M 37.06M 226.15M 226.03M 226.40M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 10.80M -100.00K -100.00K -11.60M -11.60M
Cash from Financing 72.85M 25.36M 214.45M 214.43M 214.80M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 39.38M -89.80M 44.94M 10.24M -126.10M